Hrt Financial LP Karuna Therapeutics, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$161.01 - $317.85 $5.29 Million - $10.4 Million	32,868 New	32,868 $10.4 Million
Q2 2023 Aug 11, 2023	BUY	$176.32 - $240.22 $14.3 Million - $19.4 Million	80,848 New	80,848 $17.5 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $1.09 Million - $2.44 Million	8,796 New	8,796 $1.98 Million
Q1 2022 May 16, 2022	SELL	$98.9 - $132.37 $840,551 - $1.13 Million	-8,499 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$110.64 - $159.4 $940,329 - $1.35 Million	8,499 New	8,499 $1.11 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.